Concepedia

Jose Imperio

JI

Statistics

Publications

8

Citations

835

H-Index

8

Active since

2013

Affiliations

Gene Therapy Laboratory(Current)

University of California, San Francisco

Jose Imperio is an author at Gene Therapy Laboratory specializing in neuroscience, neurodegenerative diseases, and life sciences.

Publications per year

2013–2024

8

Publications

8

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

Seung-Hye Lee, William J. Meilandt, Luke Xie et al. · Neuron · 2021 · 348 citations · Full text

, , +14

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model

William J. Meilandt, Hai Ngu, Alvin Gogineni et al. · Journal of Neuroscience · 2020 · 232 citations · Full text

, , +17

Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease

Snahel Patel, William J. Meilandt, Rebecca I. Erickson et al. · Journal of Medicinal Chemistry · 2017 · 73 citations · Full text

, , +15

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ

William J. Meilandt, Janice Maloney, Jose Imperio et al. · Alzheimer s Research & Therapy · 2019 · 44 citations · Full text

, , +17

Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS

Arundhati Sengupta-Ghosh, Sara L. Domínguez, Luke Xie et al. · Neurobiology of Disease · 2018 · 42 citations · Full text

, , +17

1–5 of 8